Posted by & filed under Company Analysis, Growth & Valuation, Management Issues.

Description: MONTREAL — Just when it seemed Valeant Pharmaceuticals Inc. was in the clear after being called out by U.S. politicians during a recent drug-pricing controversy, the Laval, Que.-based company is once again in the hot seat as it faces subpoenas from two federal prosecutors.


Date: Oct 16, 2015


Questions for Discussions:

  • What is the ethical issue here?
  • How would you expect this story to end?
  • Do you think the firm would be facing similar controversy if the products were not drugs?

Leave a Reply

Your email address will not be published. Required fields are marked *